Navigation Links
CYT003-QbG10 to treat allergy to be presented at the Congress of,the European Academy of Allergology and Clinical Immunology,(EAACI), June 9-13, 2007

Zurich, June 1, 2007-Cytos Biotechnology AG is delighted to inform you about the upcoming scientific presentations of its novel immunotherapeutic CYT003-QbG10 to treat allergic diseases. Recently, positive clinical results for CYT003-QbG10 were obtained and will be presented in different sessions at the XXVI Congress of the European Academy of Allergology and Clinical Immunology (EAACI), taking place from June 9-13, 2007 in Göteborg, Sweden. The EAACI Congress has developed into one of the most important annual events in the field of Allergy in the world. For more information please visit ww.congrex.com/eaaci2007.

CYT003-QbG10 presentations at EAACI 2007: 1) Oral presentation of Abstract No. 146: Dust mite allergy - new treatment options. Dr. med. Thomas Kündig, Head of Research, Department of Dermatology, University Hospital Zurich, Switzerland will present the CYT003-QbG10 study findings relating to house dust mite allergy on Tuesday, June 12, 2007; Oral Abstract Session 26 - Novel developments in basic allergology; 3.30 - 5.00 pm (CET).

2) Poster presentation of Abstract No. 183: A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel allergen-independent immunotherapy in patients suffering from grass pollen allergy. Presentation is on Sunday, June 10, 2007; Poster Discussion Session 1 - Immunotherapy; 10.00 - 12.00 am (CET).

3) Poster presentation of Abstract No. 714: A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel immunotherapy in patients suffering from house dust mite allergy. Presentation is on Sunday, June 10, 2007; Poster Session - Allergen SIT IV; 12.00 -1.30 pm (CET).

Background: CYT003-QbG10 is an immunotherapeutic product in development for the treatment of allergy, asthma and atopic dermatitis. It consists of the Immunodrug™ QbG10 which is comprised of the virus-like particle Qb f
'"/>




Page: 1 2

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
5. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
6. Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
7. Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy
8. Data to be presented at AAN Meeting -Study results of drug candidate for MS
9. Data supporting three Antisoma programmes presented at AACR
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/6/2009)...,, OAKLAND, Calif., Nov. 6 Kais... Hospitals (KFHP/H), and their subsidiaries report....5 billion for the quarter ended September 30, 200...of last year. Operating income in the third quarte...e third quarter of last year. Net non-operating in...
(Date:11/6/2009)...,, CHARLESTON, S.C., Nov. 6 /PRNewswire-USNew... be stopping in South Carolina and Georgia through... order to help uninsured and financially-strugglin...vide prescription medicines for free or nearly fre... 10.2 percent, the Partnership for Prescription As...
(Date:11/6/2009)...,, SAN DIEGO, Nov. 6 ...company focused on developing products for minimal...nnounced today the appointment of Michael J. Lambe... Officer, effective November 9, 2009. The Company... Team updates. ,, "Michael will be an excellent...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 1Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 2Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 3Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 4Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 5Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 6Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 7Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 8PracticeMatch Announces Departure From Physician Recruiting 53526 1PracticeMatch Announces Departure From Physician Recruiting 53526 2Operation Rescue Announces Keep It Closed Campaign 53523 1Operation Rescue Announces Keep It Closed Campaign 53523 2
...hering-Plough,Corporation (NYSE: SGP ) today repo...senapine, a fast-dissolving, sublingual tablet bei...ore effective than placebo,and well tolerated in t...ding to the results, asenapine 5 mg twice daily an...ffective than placebo at improving,patient Positiv...
...SuperGen, Inc.,(Nasdaq: SUPG ) today announced th... multi-arm Phase 1b clinical trial of MP470, a nov...(TKI). The trial will evaluate,MP470 in combinatio...ens,including carboplatin/paclitaxel, carboplatin/... trial is expected to enroll up to 105,patients at...
Other Medicine Technology:New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 2New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 3New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia 4SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 3
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...a press conference following the House passage of ...Act. The bill passed by a vote of 220 to 215. Be...nd some of my colleagues just received a call from... congratulating us on a great victory for the Amer...
(Date:11/8/2009)... Men’s Health Networ...ir health risks, especially those linked to exposu...rom military service. Bladder cancer is one of tho...erans, especially those who once smoked or current...shington DC (PRWEB) November 8, 2009 -- Men’...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...dable Health Care for America Act, which will make...nsurance companies accountable and increase access...a public option. ,, "Teddy Roosevelt, FDR and H... Director Alan Charney. "Today,s vote ranks among ...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Workin...RG, Pa., Nov. 8 On the ...of Representatives for a good, balanced health car...ts scoring of how our state,s U.S. representatives...America Act. ,, The legislation, which passed ...
(Date:11/7/2009)..., HOUSTON, Nov. 7, T...d its 2009 Benjamin Rush Award for Citizenship and...thalmologist from Chicago, IL. The award recognize...professional call of duty to make an outstanding p...y. Dr. Kraff received the award today during the o...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...at the proposed Government plan to reduce the wait... be achieved without a substantial expansion of th...t in the health care facilities has also to be und...spread of sexually transmitted diseases. Dr. Helen...
...been warned of fines by the Government if it were ... services. Copeman Healthcare intends to establish... has announced that it will be charging a joining ...an be levied for every incident wherein charges ar...
...) patients, currently on a six-month waiting list ...ment report that would be released this Friday. //...at the maximum waiting period would not exceed six...Figures for November showed that more than 12, 300...
...atients afflicted by cancer, open heart surgeries,...everal others who are in need of blood platelet tr...at the University of British Columbia's Centre for...lood platelets are vital to promote clotting of bl...
...uter model has been developed that can predict the...ty whether it would be mild or severe can be told ... ample time for preventive or emergency measures t...sub-Saharan Africa. And it kills millions of peopl...
...ave revealed that they might have made a breakthro...anian devils. // These tumors spread by biting and...imals are mating, the researchers said. Devil ...the affected devil, "What we've shown, or we've sh...
Other Medicine News:Health News:Quality Platelets and Improved Blood Availability No Longer a Pipe Dream 2Health News:Prediction of malaria epidemics possible! 2
...medium designed for the direct detection and/or co...ted for the suppression of gram-negative organisms...eus hydrolyzes the chromogenic substrate resulting...n from other gram-positive organisms. A cephalospo...
Autoclavable Light Guides & Adapters
...h a 180 watt Xenon short arc lamp. Designed to pro... transfer from the lamp to the light guide, this l...alent to higher watt bulbs. A new IR filtering sys...mount of heat generated from the light source and ...
... your video equipment has led Linvatec to develop ...odate all of your multi-specialty video requiremen...ers in both traditional eyecup and proprietary fog...oom "C mount eyecup and both "C and "V mount eyecu...
Medicine Products: